Notice for pyrazinamide (AFT Pharmaceuticals Pty Ltd)
Active ingredients
pyrazinamide
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Tablet
Indication
Indicated in patients with active tuberculosis caused by Mycobacterium tuberculosis
Therapeutic area
Infectious diseases